AAAAAA

   
Results: 1-9 |
Results: 9
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: Results of a phase II trial
Authors: Schmidinger, M Stager, G Wenzel, C Locker, GJ Budinsky, AC Brodowicz, T Kramer, G Marberger, M Zielinski, CC
Citation: M. Schmidinger et al., Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: Results of a phase II trial, J IMMUNOTH, 24(3), 2001, pp. 257-262
Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancerpatients
Authors: Locker, GJ Wenzel, C Schmidinger, M Gnant, MFX Marosi, C Jakesz, R Zielinski, CC Steger, GG
Citation: Gj. Locker et al., Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancerpatients, ANTI-CANC D, 12(3), 2001, pp. 209-212
Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial
Authors: Schmidinger, M Budinsky, AC Wenzel, C Locker, GJ Pluschnig, U Brodowicz, T Kubista, E Maca, S Zabernigg, A Ilsinger, P Seewann, L Hojas, S Blach, M Zielinski, CC Steger, GG
Citation: M. Schmidinger et al., Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial, CANC CHEMOT, 47(1), 2001, pp. 57-62
Has there been progress in pharmacotherapy for breast cancer patients?
Authors: Wenzel, C Schmidinger, M Huber, H
Citation: C. Wenzel et al., Has there been progress in pharmacotherapy for breast cancer patients?, WIEN KLIN W, 113(9), 2001, pp. 306-320
Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma
Authors: Schmidinger, M Steger, GG Budinsky, AC Wenzel, C Brodowicz, T Locker, GJ Kramer, G Marberger, M Zielinski, CC
Citation: M. Schmidinger et al., Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma, ANTI-CANC D, 11(3), 2000, pp. 175-179
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial
Authors: Schmidinger, M Steger, GG Wenzel, C Locker, GJ Brodowicz, T Budinsky, AC Wiltschke, C Kramer, G Marberger, M Zielinski, CC
Citation: M. Schmidinger et al., Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial, CANCER IMMU, 49(7), 2000, pp. 395-400
Karyotypic findings in two cases of male breast cancer
Authors: Rudas, M Schmidinger, M Wenzel, C Okamoto, I Budinsky, A Fazeny, B Marosi, C
Citation: M. Rudas et al., Karyotypic findings in two cases of male breast cancer, CANC GENET, 121(2), 2000, pp. 190-193
Glutathione in the prevention of cisplatin induced toxicities - A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer
Authors: Schmidinger, M Budinsky, AC Wenzel, C Piribauer, M Brix, R Kautzky, M Oder, W Locker, GJ Zielinski, CC Steger, GG
Citation: M. Schmidinger et al., Glutathione in the prevention of cisplatin induced toxicities - A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer, WIEN KLIN W, 112(14), 2000, pp. 617-623
Clinical phase II evaluation of the combination therapy with Docetaxel andEpidoxorubicin in the neoadjuvant, cytostatic treatment on patients with primary breast cancer (T1-4, N0-2, M0)
Authors: Wenzel, C Schmidinger, M Locker, GJ Taucher, S Gnant, M Jakesz, R Steger, GG
Citation: C. Wenzel et al., Clinical phase II evaluation of the combination therapy with Docetaxel andEpidoxorubicin in the neoadjuvant, cytostatic treatment on patients with primary breast cancer (T1-4, N0-2, M0), WIEN KLIN W, 111(20), 1999, pp. 843-850
Risultati: 1-9 |